CJC-1295 No DAC + Ipamorelin Blend: Specifications and Research Context
CJC-1295 (No DAC) 5 mg + Ipamorelin 5 mg research blend
A two-component, lyophilized research blend for controlled laboratory work. Not for human or veterinary use.
CJC 1295 Ipamorelin Blend Mechanism and Current Evidence
Two receptor systems with a shared growth-hormone-axis endpoint
This CJC 1295 Ipamorelin Canada blend combines 5 mg of a no-DAC GHRH analogue with 5 mg of ipamorelin. CJC-1295 (No DAC), a name commonly used for modified GRF (1-29), targets the growth-hormone-releasing hormone receptor. Ipamorelin targets the growth hormone secretagogue receptor, also called GHS-R1a.
CJC/IPA is shorthand for a CJC-1295 and Ipamorelin combination. This listing specifically contains the No DAC form of CJC-1295, with 5 mg of each ingredient per vial.
The two components activate different signalling systems in pituitary research models. GHRH-receptor activation drives Gαs, cAMP and protein kinase A signalling. Ipamorelin acts through a GHRP-like receptor pathway associated with Gαq, phospholipase C and intracellular calcium. Primary studies with GHRH plus ghrelin or other growth hormone secretagogues have reported greater GH responses than either pathway produced alone.
Researchers should separate evidence for the mechanism from evidence for this exact premixed product. Published work supports ipamorelin pharmacology, GHRH and GHS pathway interactions, and CJC-1295 with DAC. Controlled studies of this exact no-DAC CJC-1295 plus ipamorelin blend remain limited. The long half-life reported for DAC-linked CJC-1295 does not apply to a no-DAC preparation.
Primary research: Raun et al., ipamorelin pharmacology · Hataya et al., GHRH and ghrelin interaction · Teichman et al., CJC-1295 with DAC
Purity, Batch COA and Third-Party Testing
A blend report must account for both peptide components
The storefront lists the CJC 1295 research peptide and ipamorelin components as independently tested to at least 99% chromatographic purity, with mass-spectrometry confirmation. Researchers should match the vial lot to a batch-specific report before starting work.
A two-component blend requires a method that can resolve and identify both analytes. Review the chromatogram, reported masses, test date, laboratory name and lot identifier. A purity percentage for one component does not establish the purity or quantity of the other.
HPLC and mass spectrometry do not prove the stated blend ratio, total vial fill, sterility, endotoxin status, biological activity, efficacy or safety unless the laboratory reports those properties through separate validated tests.
CJC-1295 No DAC + Ipamorelin 5 mg/5 mg: blend and standalone options
No-DAC, DAC-linked and standalone research forms are not interchangeable
This listing contains two peptides in one vial: 5 mg CJC-1295 No DAC and 5 mg Ipamorelin. For separate ingredient studies, see standalone CJC-1295 No DAC 10 mg and standalone Ipamorelin 5 mg.
| Research form | Defining feature | Availability on this page |
|---|---|---|
| CJC-1295 (No DAC) | Modified GHRH fragment without the drug-affinity-complex group | 5 mg in the blend |
| Ipamorelin | Five-residue GHS-R agonist | 5 mg in the blend |
| CJC-1295 with DAC | Albumin-binding, long-acting DAC-linked analogue | Different research form |
CJC-1295 with DAC is a different research form. Read our DAC vs No DAC comparison for that distinction, or CJC-1295 vs Ipamorelin for a comparison of the two ingredients.
Explore Anglo Peptides Canada · Buy Peptides Canada · Tesamorelin Canada · Sermorelin Canada
Buying the CJC-1295 + Ipamorelin blend in Canada
One 5 mg + 5 mg vial, shipped within Canada
The current price and availability above apply to one 5 mg + 5 mg lyophilized blend vial, containing 10 mg total peptide. Orders ship within Canada by Canada Post Xpresspost. Business-day orders placed before 2:30 p.m. Eastern are dispatched the same day under our shipping policy. Typical delivery is 1–3 business days to major centres, with additional time for remote destinations. Tracking is provided when the shipping label is generated. See Shipping & Returns for full terms.
Reconstitution, Stability and Laboratory Storage in Canada
Document conditions for both peptides in the blend
Store the unopened lyophilized vial at the condition shown on its label and batch documentation.
After reconstitution, the solvent or buffer, pH, concentration, container, temperature, light exposure and freeze-thaw history can affect each component. A blend can lose one component faster than the other. Laboratories should validate solution stability and the CJC-to-ipamorelin ratio for the selected protocol.
The peptide calculator provides concentration and dilution arithmetic. It does not choose a solvent, establish stability, replace a validated protocol or provide human dosing guidance.







Tyler B. –
Love this blend, saves me ordering CJC and ipa separately. Came fast, reconstituted perfectly. Price is really good for the combo. Anglo is my regular source now.
Amira D. –
Second order of this blend and same great experience. Shipped same day, arrived in two days to Montreal. No issues with the product at all. Great source.
Isabelle D. –
Really love this blend. Second time ordering and both times shipped same day. The convenience of having CJC and ipa together at this price is hard to beat.
Paul K. –
Really convenient not having to grab CJC and ipa separately. Arrived well packaged, dissolved clean. Anglo\’s been my go-to Canadian source for a while and this blend is no exception.
Henry P. –
The blend vial is incredibly convenient. Both peptides dissolved cleanly and the COA covers each component separately from Janoshik. Same-day Xpresspost to BC, arrived in 2 days.
Emma C. –
Great combo product from a Canadian manufacturer. Makes my protocol simpler and the pricing is very competitive. Packaging is professional and everything was properly cold-packed.
Zach N. –
Convenient blend, good quality, fast shipping to Ottawa. Both peptides reconstituted cleanly. Would be 5 stars if the combo came in a 10mg+10mg option too.